News

When considering premium surgeries and high expectations from patients along with an unrelenting quest for vision exceeding 20/20, the tolerance of residual astigmatism must be zero. Like bespoke tailors, ophthalmologists need to be bespoke surgeons who tailor vision in each eye to the highest level possible. We cannot claim to design the best suit using the best technology and tailoring materials, and yet, in our minds, find it “acceptable” to have the suit length within a half-inch to three-quarters of an inch too short or wide.

Implantation of a sulcus-supported, pseudophakic supplementary intraocular lens (IOL) can be a safe and effective method for improving vision in eyes with residual refractive error after cataract extraction, refractive lens exchange, or keratoplasty, said Thomas Kohnen, MD, PhD. It also can be used to provide reversible presbyopia correction.

David Karcher, executive director and chief executive officer, The American Society of Cataract and Refractive Surgery (ASCRS), will retire as of December 31, 2018, according to an ASCRS press release. Eric D. Donnenfeld, MD, will chair the search committee responsible for interviewing candidates to fill the role of executive director. Interviews will begin in the late summer or early fall of 2017. Leonard Pfeiffer & Company, a well-known executive search firm, will be assisting in the search.

The ophthalmic community mourns the loss of Roger Steinert, MD, an internationally renowned and respected corneal, cataract, and refractive surgeon. Dr. Steinert passed away on June 6 at the age of 66 after a 2 ½-year battle with glioblastoma. He died peacefully at his home in Colorado, surrounded by his wife, April, and their family.

No doubt, you, dear reader, have experienced the unpleasant situation of terminating an employee for one reason or another (poor performance, financial exigencies, etc.). But I would hope that we ophthalmologists perform this task in a more professional manner than that exemplified by The Captain of Industry.

The implementation of electronic health records has had great impact on the way ophthalmologists spend their time. There are concerns that this has created inefficiencies, and that physicians now spend more time documenting, and less time with their patients, which is the opposite of what was intended.

A review of 800 cases of small incision lenticule extraction for treatment of myopia and myopic astigmatism shows an evolution in surgical indications and technique with consistently positive outcomes.

As part of a transformation to one of the pioneering eye banks in the country, Tissue Banks International (TBI) recently underwent a formal rebranding, changing its name to Kera­Link International. This move included shedding the musculoskeletal portion of operations to concentrate on dramatically increasing the number of sight-saving procedures performed globally, explained Douglas Furlong, Kera­Link’s president and chief executive officer.

There is nothing you can do to help a person modify his or her behavior, or to modify a clinic behavior, if the person simply does not see-or will not acknowledge-this behavior within himself or herself.

A new imaging technique can show the deaths of individual cells in people with glaucoma by labelling the cells with fluorescent dye, according to researchers. The approach might eventually be used to diagnosis the disease in its early stages or measure its progression.

One of the biggest challenges for ophthalmologists, especially in the field of refractive surgery, is to define ourselves (in professional terms) and set our goals.

For 20 years I have effectively employed endoscopic cyclophotocoagulation (ECP) as a primary or secondary line of glaucoma treatment. ECP is a minimally invasive glaucoma surgical (MIGS) option capable of reducing IOP in the majority of patients and can potentially eliminate the need for drainage surgery, including trabeculectomy (trab) and glaucoma drainage devices (GDDs).

At the 2006 ASCRS Film Festival, Dr. Malyugin, professor of ophthalmology and deputy director, S. Fyodorov Eye Microsurgery Institution, Moscow, received the first-place award in the instruments/devices category for his video, “Russian solution to small-pupil phaco and tamsulosin floppy-iris syndrome,” that presented the pupil expansion ring he designed for atraumatic management of the small pupil.

Cirle Inc. announced the unveiling of its latest three-dimensional Surgical Navigation System (SNS 200) at the 2017 meeting of the American Society of Cataract and Refractive Surgery. The investigational system is completing FDA registration.